Background The correlation between sarcopenia and hematological malignancy prognosis
is still controversial. Design: A systematic review and meta-analysis. Objectives: To explore …

Background & aims Our purpose was to analyze influence of sarcopenia on overall survival
(OS) in patients with malignant hematological diseases (MHD) based on a large sample …

Background & aims Evidence regarding the prevalence of pre-treatment sarcopenia and its
impact on survival in patients with hematological malignancies (HM) varies across studies …

Simple Summary Sarcopenia is a geriatric syndrome characterized by progressive and
generalized loss of muscle strength and muscle mass. It associated with reduced physical …

Objective Although previous studies have implicated the negative outcomes of sarcopenia,
evidence is limited to one or a few types of cancer. The aim of this study was to evaluate the …

Purpose Sarcopenia is increasingly recognized as an independent risk factor for poor
outcomes in patients undergoing hematopoietic stem cell transplantation (HSCT), and it is a …

Background Acute myeloid leukemia (AML) occurs frequently in the elderly, of whom the
prognosis is dismal. Sarcopenia is a progressive and generalized skeletal muscle disorder …

Objectives The aim of this meta-analysis is to comprehensively evaluate the effects of lean
mass on all-cause mortality across different cancer types. Methods This is a meta-analysis …

Objectives Sarcopenia has been an emerging theme in clinical oncology. Various definitions
of sarcopenia have been proposed, but their prognostic performance have yet to be …

Background Body composition plays an important role in predicting treatment outcomes in
adults with cancer. Using existing computed tomographic (CT) cross-sectional imaging and …